Works matching IS 03125963 AND DT 2001 AND VI 40 AND IP 3

Results: 9

Delavirdine.

Published in:

Clinical Pharmacokinetics, 2001, v. 40, n. 3, p. 207, doi. 10.2165/00003088-200140030-00005

By:

Tran, Jonathan Q.;
Gerber, John G.;
Kerr, Bradley M.

Publication type:

Article

The gut as a barrier to drug absorption: combined role of cytochrome P450 3A and P-glycoprotein.

Published in:

2001

By:

Zhang, Y;
Benet, L Z

Publication type:

journal article

Multiple Dose Pharmacokinetics of a New Once Daily Extended Release Tolterodine Formulation Versus Immediate Release Tolterodine.

Published in:: Clinical Pharmacokinetics, 2001, v. 40, n. 3, p. 227, doi. 10.2165/00003088-200140030-00006
Publication type:: Article

Delavirdine: clinical pharmacokinetics and drug interactions.

Published in:

2001

By:

Tran, J Q;
Gerber, J G;
Kerr, B M

Publication type:

journal article

Pharmacokinetics and pharmacodynamics of the triptan antimigraine agents: a comparative review.

Published in:

2001

By:

Jhee, S S;
Shiovitz, T;
Crawford, A W;
Cutler, N R

Publication type:

journal article

The erythromycin breath test for the prediction of drug clearance.

Published in:

2001

By:

Rivory, L.P.;
Slaviero, K.A.;
Hoskins, J.M.;
Clarke, S.J.

Publication type:

journal article

The Gut as a Barrier to Drug Absorption.

Published in:

Clinical Pharmacokinetics, 2001, v. 40, n. 3, p. 159, doi. 10.2165/00003088-200140030-00002

By:

Zhang, Y.;
Benet, L.Z.

Publication type:

Article

Comparative pharmacokinetics and pharmacodynamics of the newer fluoroquinolone antibacterials.

Published in:

2001

By:

Aminimanizani, A.;
Beringer, P.;
Jelliffe, R.

Publication type:

journal article

Pharmacokinetics and Pharmacodynamics of the Triptan Antimigraine Agents.

Published in:

Clinical Pharmacokinetics, 2001, v. 40, n. 3, p. 189, doi. 10.2165/00003088-200140030-00004

By:

Jhee, S.S.;
Shiovitz, T.;
Crawford, A.W.;
Cutler, N.R.

Publication type:

Article